## Big Pharma makes money by creating multiple variations of drugs to extend patent life

The hidden business model of Big Pharma is to turn one drug into manyâ€”by turning out minor variations that extend patent life; and through clinical trial administration, research publication, regulatory lobbying, physician and patient education, drug pricing, advertising, and point-of-use promotion to create distinct bio marketing profiles and brand loyalty for otherwise similar products. Why? Because generic drugs are cheaper; by slightly tweaking their ingredient list, they get more time on patent protection. Hey, if it didnâ€™t work, you know they wouldnâ€™t be doing it.

---

##### References

* Lustig, Robert. (2021). [Metabolical Chapter 6. Because Big Pharma Was Their Teacher](Metabolical%20Chapter%206.%20Because%20Big%20Pharma%20Was%20Their%20Teacher.md) (p. 119). New York, NY: *HarperCollins Publishers*.

##### Metadata

Type: #ğŸ”´ 
Tags: [Medicine](Medicine.md) 
Status: #â˜€ï¸ 
